Amgen sees no bone safety concerns around experimental obesity drug-February 2024-www.financetom.com

Amgen sees no bone safety concerns around experimental obesity drug

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Amgen sees no bone safety concerns around experimental obesity drug

Nov 13, 2024 11:28 AM

(Reuters) - Amgen ( AMGN ) said on Wednesday it does not see any bone safety concerns around the use of its experimental obesity drug, a day after data from an early-stage study dragged its stock 7% lower.

(Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)

Previous page： Hugo Boss cuts full-year forecast on sagging China, UK demand Next page： Chinese state-owned brokerage to ramp up investment banking business in Southeast Asia

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Hugo Boss cuts full-year forecast on sagging China, UK demand

Jul 16, 2024

* Expects FY sales at 4.20-4.35 bln euros, EBIT at 350-430 mln euros * Q2 EBIT of 70 mln euros misses expectations * Shares fall 10%, hitting lowest level since April 2021 (Adds analyst comment in paragraph 4 and 7, shares in paragraph 6, context in paragraphs 8-9) By Gursimran Mehar and Linda Pasquini July 15 (Reuters) - German fashion...

Chinese state-owned brokerage to ramp up investment banking business in Southeast Asia

Jul 16, 2024

By Yantoultra Ngui SINGAPORE (Reuters) - A unit of state-owned brokerage China Galaxy Securities (CGS) plans to expand its investment banking team in Southeast Asia to 50 people next year from 30 now, a senior executive said, betting on a rise in dealmaking in the region amid a sluggish market at home. CGS International Securities is also in the process...

Dollar steadies as Sept rate cut back in focus, yen wobbles

Jul 16, 2024

SINGAPORE (Reuters) -The dollar inched away from five-week lows on Tuesday, as investors weighed the case for a September rate cut after comments by Fed Chair Jerome Powell and pondered rising odds for the re-election of former U.S. President Donald Trump. The dollar's slight strengthening put the Japanese yen back under pressure, with traders wary of further intervention by Tokyo...

Jul 16, 2024

...